s6y

QuidelOrtho Corp

Ticker
QDEL
CIK
1906324
Industry
In Vitro & In Vivo Diagnostic Substances
Formerly
Coronado Topco, Inc.

Financials 19

  1. 10-Q Quarterly Report for period ending Sep 27, 2026
  2. 10-Q Quarterly Report for period ending Jun 28, 2026
  3. 10-Q Quarterly Report for period ending Mar 29, 2026
  4. 10-K Annual Report for period ending Dec 28, 2025
  5. 10-Q Quarterly Report for period ending Sep 28, 2025
  6. 10-Q Quarterly Report for period ending Jun 29, 2025
  7. 10-Q Quarterly Report for period ending Mar 30, 2025
  8. 10-K Annual Report for period ending Dec 29, 2024
  9. 10-Q Quarterly Report for period ending Sep 29, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 19 financials filings

News 56

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 56 news filings

Ownership 362

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 362 ownership filings

Prospectus 11

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-4/A Registration of securities issued in business combination transactions
  10. S-4/A Registration of securities issued in business combination transactions

All 11 prospectus filings

Proxies 8

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements

Other 48

  1. SCHEDULE 13G/A
  2. SCHEDULE 13G
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G
  7. SCHEDULE 13G/A
  8. SCHEDULE 13G
  9. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  10. SCHEDULE 13G/A

All 48 other filings